Peer review reports
From: Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Original Submission |
4 Jul 2014 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
27 Feb 2015 |
Editorially accepted |
|
14 Mar 2015 |
Article published |
10.1186/s12885-015-1143-y
|
Learn about peer review